Choriogonadotropin alfa is a recombinant form of human chorionic gonadotropin (hCG) that acts as an agonist at the luteinizing hormone/choriogonadotropin receptor. It is used to induce final follicular maturation and ovulation in infertile women, and in the Pregnyl label also in cryptorchidism and hypogonadotropic hypogonadism in males.
Summary written with AI from the sources listed at the end of this page.
Infertility (induction of final follicular maturation and early luteinization in ART programs) (Ovidrel)
Anovulatory infertility (induction of ovulation and pregnancy) (Ovidrel)
Prepubertal cryptorchidism not due to anatomical obstruction (Pregnyl)
Hypogonadotropic hypogonadism in males (Pregnyl)
Induction of ovulation and pregnancy in anovulatory infertile women (Pregnyl)
From the indications section of the FDA label (version of Dec 26, 2023). Read the full label for the exact wording, limitations and safety information.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.